HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Personal Folders Download to citation manager Permission Requests Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Haider, W. Articles by Wolner, E. Search for Related Content PubMed PubMed Citation Articles by Haider, W. Articles by Wolner, E.

The Journal of Thoracic and Cardiovascular Surgery, Vol 88, 294-300, Copyright © 1984 by The American Association for Thoracic Surgery and The Western Thoracic Surgical Association

ARTICLES

Improvement of cardiac preservation by preoperative high insulin supply

W Haider, H Benzer, W Schutz and E Wolner

Therapeutic administration of high doses of insulin achieves a shifting of metabolism to glycogenesis and glycolysis. The result is an accumulation of the myocardial glycogen stores and an improvement of glucose utilization as well. If on that basis an increased anaerobic provision of adenosine triphosphate will be maintained in the myocardium during ischemia, the myocardial cell viability during aortic cross-clamping will be saved as well. Thus a preventive insulin supply will preserve the heart from ischemic damage. Twenty patients undergoing mitral valve replacement were investigated in two randomized groups. One group received insulin (1 U/kg/hr) together with a 33% glucose infusion (0.5 gm/kg/h) and potassium (0.25 mEq/kg/hr) from the onset of anesthesia until aortic cross-clamping. The control group received Ringer's lactate at the same infusion rate. After an average ischemic time of 26 minutes, an excised papillary muscle tip was immediately plunged into liquid nitrogen and the content of adenosine triphosphate, adenosine diphosphate, and creatine phosphate was determined. The adenosine triphosphate/diphosphate quotient and the energy charge potential were calculated. The mean adenosine triphosphate content in the insulin group was 7.43 mumol/gm wet weight and was significantly (p less than 0.01) higher than that of the control group (4.28 mumol/gm). The mean ADP content was 1.43 mumol/gm in the insulin group versus 1.81 mumol/gm in the control group. The mean creatine phosphate content was again significantly (p less than 0.05) higher in the insulin group (6.70 mumol/gm) than in the control group (5.30 mumol/gm). Also, the mean adenosine triphosphate/diphosphate quotient (insulin group, 5.19; control group, 2.36) and the mean energy charge potential (insulin group, 0.919; control group, 0.851) were significantly (p less than 0.01) higher in the insulin group. It is concluded that the preventive application of high doses of insulin leads to an augmented myocardial adenosine triphosphate provision and a maintained cellular energy charge during coronary ischemia. As a result, ischemic tolerance is enhanced and myocardial protection is improved.

This article has been cited by other articles:

				Y. Fan, A.-M. Zhang, Y.-B. Xiao, Y.-G. Weng, and R. Hetzer Glucose-insulin-potassium therapy in adult patients undergoing cardiac surgery: a meta-analysis Eur J Cardiothorac Surg, July 1, 2011; 40(1): 192 - 199. [Abstract] [Full Text] [PDF]

				T. B. Albacker, G. Carvalho, T. Schricker, and K. Lachapelle Myocardial Protection During Elective Coronary Artery Bypass Grafting Using High-Dose Insulin Therapy Ann. Thorac. Surg., December 1, 2007; 84(6): 1920 - 1927. [Abstract] [Full Text] [PDF]

				J. D. Schipke, R. Friebe, and E. Gams Forty years of glucose-insulin-potassium (GIK) in cardiac surgery: a review of randomized, controlled trials Eur J Cardiothorac Surg, April 1, 2006; 29(4): 479 - 485. [Full Text] [PDF]

				W. Bothe, M. Olschewski, F. Beyersdorf, and T. Doenst Glucose-Insulin-Potassium in Cardiac Surgery: A Meta-Analysis Ann. Thorac. Surg., November 1, 2004; 78(5): 1650 - 1657. [Abstract] [Full Text] [PDF]

				J.-T. Kim, C.-W. Jung, and K.-H. Lee The Effect of Insulin on the Resuscitation of Bupivacaine-Induced Severe Cardiovascular Toxicity in Dogs Anesth. Analg., September 1, 2004; 99(3): 728 - 733. [Abstract] [Full Text] [PDF]

				H. Taegtmeyer Improving Energy Metabolism in the Postischemic Heart-The Story of GIK Seminars in Cardiothoracic and Vascular Anesthesia, March 1, 2003; 7(1): 67 - 76. [Abstract] [PDF]

				T. Doenst, W. Bothe, and F. Beyersdorf Therapy with insulin in cardiac surgery: controversies and possible solutions Ann. Thorac. Surg., February 1, 2003; 75(2): S721 - S728. [Abstract] [Full Text] [PDF]

				P.M. Piatti, L.D. Monti, G. Valsecchi, M. Conti, R. Nasser, B. Guazzini, E. Fochesato, C.V. Phan, A.E. Pontiroli, and G. Pozza Effects of Low-Dose Heparin Infusion on Arterial Endothelin-1 Release in Humans Circulation, December 1, 1996; 94(11): 2703 - 2707. [Abstract] [Full Text]

				V. T. Sanchala and M. A. Inchiosa Jr Preoperative glucose-insulin-K+ therapy for cardiac protection: What can be recommended? Ann. Thorac. Surg., August 1, 1993; 56(2): 395 - 395. [PDF]

				R. D. Weisel, D. A. G. Mickle, C. D. Finkle, L. C. Tumiati, M. M. Madonik, and J. Ivanov Delayed Myocardial Metabolic Recovery After Blood Cardioplegia Ann. Thorac. Surg., October 1, 1989; 48(4): 503 - 507. [Abstract] [PDF]

				J. W. Stephens, A. H. Krause, C. A. Peterson, J. J. Bass, J. E. Hartman, N. W. Salomon, and W. K. Ward The Effect of Glucose Priming Solutions in Diabetic Patients Undergoing Coronary Artery Bypass Grafting Ann. Thorac. Surg., May 1, 1988; 45(5): 544 - 547. [Abstract] [PDF]